Search

everythinglearnresearchcommunity

for

Search:↓

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Early-stage Alopecia Areata was effectively treated in less than six months.

Older patients sticking to their prostate medication saw lasting health benefits.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

The treatment was ineffective in humans.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Apremilast did not work for treating severe alopecia areata.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Dutasteride is safe and effective long-term for male hair loss.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.